Zeus Opens State-of-the-Art Facility

Zeus, a global leader in advanced polymer solutions, announced today that construction is almost complete on a state-of-the-art catheter manufacturing facility in Arden Hills, Minnesota. The location, scale, and on-site capabilities across R&D, design, and development will advance catheter innovation and strengthen Zeus’s strategic partnerships with OEMs and medical device customers.

“The Minnesota facility is an important step in our geographic expansion for several reasons,” said Steve Peterson, President and CEO of Zeus. “The state has a long track record in medical device innovation, and locating closer to customers will support deeper collaboration across early-stage catheter design and development. Furthermore, this facility allows us to scale catheter manufacturing significantly to meet growing global customer and market demand.”

Scheduled to open in summer 2023, this custom 75,600 square feet facility includes an advanced R&D lab and cleanroom equipped with the latest technologies to design, develop, and validate new catheter prototypes in industry-best lead times. It also brings additional capabilities in-house to Zeus, including laser cutting, ablation, and welding.

“This facility opens the door to expanding our end-to-end catheter design and manufacturing capabilities, all under one roof. It’s a big step for our customers and the industry,” said Suresh Sainath, General Manager for Zeus’ catheter solutions division. “It also represents a building block for future strategic collaboration between our catheter and polymer customers, enabling industry-defining catheter innovation going forward.”

As well as proximity to current customers, the Arden Hills, MN, location was selected for its easy access to local transportation and amenities for the company’s expanding workforce. Following an agreement with DEED as part of the Minnesota Job Creation Fund (JCF), this new facility is expected to create 100-plus new jobs in the coming years. Positions will include engineers, project managers, technicians, and product builders.

Hot this week

Recor Medical Supports European Society of Cardiology’s Hypertension Guidelines

Record Medical notes the new guidelines, "2024 ESC Guidelines for the management of elevated blood pressure and hypertension," have been published online and recommend the consideration of renal denervation (RDN) as a safe and effective treatment option for patients who have uncontrolled resistant hypertension or those that have uncontrolled hypertension with a higher risk of cardiovascular disease, who express a preference to undergo RDN.

ConTIPI Medical Selects EVERSANA to Support U.S. Commercialization of Non-Surgical Medical Device ProVate for Women with Pelvic Organ Prolapse

EVERSANA is a leading provider of global commercial services to the life sciences industry, to support commercialization for the ProVate device in the United States to help women experiencing pelvic organ prolapse.

Boston Scientific Obtains CE Mark for ACURATE Prime Aortic Valve System

The ACURATE Prime aortic valve system is designed with several features to build upon the clinical performance of the ACURATE neo2™ platform including an additional valve size, which expands the treatment range to patients with a larger anatomy.

Noctrix Health Announces New CMS Reimbursement Codes and Payment for Nidra Tonic Motor Activation Therapy for Restless Legs Syndrome

Nidra TOMAC Tonic Motor Activation Therapy, which was authorized for marketing in the United States last year following its designation as a "Breakthrough Device" by the US Food & Drug Administration (FDA), remains the only clinically validated, non-pharmaceutical treatment available for patients with RLS.

Haemonetics Announces Full Market Release for VASCADE MVP® XL Vascular Closure System

Haemonetics notes the VASCADE MVP XL system is now available to U.S. hospitals as the newest addition to Haemonetics' VASCADE® portfolio of vascular closure systems featuring an innovative collapsible disc technology and a proprietary resorbable collagen patch designed to promote rapid hemostasis.